发明名称 |
Titration package for neramexane and its use in the treatment of an inner ear disorder |
摘要 |
The present invention relates to a titration scheme for the administration of a 1-amino-alkylcyclohexane derivative which allows for quick attainment of an effective dose of a 1-amino-alkylcyclohexane derivative while minimizing side effects. The present invention further relates to a titration package for providing a 1-amino-alkylcyclohexane derivative (e.g., neramexane or a pharmaceutically acceptable salt thereof) in at least two different dosages. The present titration scheme/titration package may be useful in the treatment of various diseases, including tinnitus. |
申请公布号 |
US8877814(B2) |
申请公布日期 |
2014.11.04 |
申请号 |
US200812733645 |
申请日期 |
2008.09.10 |
申请人 |
Merz Pharma GmbH & Co. KGaA |
发明人 |
Ellers-Lenz Barbara;Rosenberg Tanja;Seiller Erhard;Kruger Hagen;Althaus Michael |
分类号 |
A61K31/13;A61P27/16;C07C211/35;A61K9/20 |
主分类号 |
A61K31/13 |
代理机构 |
Hueschen and Sage |
代理人 |
Hueschen and Sage |
主权项 |
1. A method of treating tinnitus, in a subject in need thereof, comprising administration of a therapeutically effective amount of a 1-amino-alkylcyclohexane derivative selected from neramexane and pharmaceutically acceptable salts thereof, wherein the 1-amino-alkylcyclohexane derivative is administered in a titration scheme comprising up titration of the 1-amino-alkylcyclohexane derivative in increasing dosages of 25 mg or 12.5 mg steps at weekly intervals over a period of four weeks to achieve a body weight-adjusted target dose of 50 mg/day for patients with a body weight of up to 90 kg, or over a period of five weeks to achieve a body weight-adjusted target dose of 75 mg/day for patients with a body weight of equal to or greater than 90 kg. |
地址 |
Frankfurt am Main DE |